Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.272
-0.028 (-9.30%)
Mar 6, 2026, 4:00 PM EST
Integrated BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 9 | 11 | 6 | 10 | 15 | 33 | Upgrade
|
| Market Cap Growth | 8.50% | 75.42% | -36.28% | -33.74% | -54.33% | 146.41% | Upgrade
|
| Enterprise Value | 5 | 9 | 6 | 10 | 19 | 41 | Upgrade
|
| Last Close Price | 0.30 | 0.36 | 0.21 | 0.33 | 0.50 | 1.10 | Upgrade
|
| PE Ratio | - | 13.72 | 56.44 | - | 3.90 | 4.09 | Upgrade
|
| PS Ratio | 0.18 | 0.20 | 0.13 | 0.20 | 0.27 | 0.52 | Upgrade
|
| PB Ratio | 0.47 | 0.55 | 0.33 | 0.53 | 0.81 | 2.29 | Upgrade
|
| P/TBV Ratio | 0.47 | 0.55 | 0.33 | 0.53 | 0.81 | 2.29 | Upgrade
|
| P/FCF Ratio | 3.30 | 5.92 | 16.21 | 8.89 | 4.15 | 11.90 | Upgrade
|
| P/OCF Ratio | 2.98 | 5.37 | 6.70 | 8.05 | 3.66 | 10.75 | Upgrade
|
| EV/Sales Ratio | 0.09 | 0.17 | 0.13 | 0.20 | 0.35 | 0.64 | Upgrade
|
| EV/EBITDA Ratio | 2.38 | 3.96 | 11.36 | 21.85 | 6.31 | 6.68 | Upgrade
|
| EV/EBIT Ratio | 7.82 | 4.59 | 25.26 | 85.75 | 7.08 | 7.07 | Upgrade
|
| EV/FCF Ratio | 1.60 | 4.94 | 16.26 | 9.22 | 5.39 | 14.84 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.05 | 0.09 | 0.14 | 0.11 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.27 | 0.30 | 1.15 | 1.91 | 0.55 | 0.84 | Upgrade
|
| Debt / FCF Ratio | 0.18 | 0.54 | 4.61 | 2.39 | 0.57 | 2.18 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.13 | 0.01 | 0.07 | 0.09 | 0.40 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.45 | -1.11 | 0.22 | 2.88 | 0.56 | 0.94 | Upgrade
|
| Net Debt / FCF Ratio | -1.70 | -1.39 | 0.31 | 1.22 | 0.48 | 2.08 | Upgrade
|
| Asset Turnover | 2.12 | 2.13 | 1.95 | 2.00 | 2.22 | 2.63 | Upgrade
|
| Inventory Turnover | 4.94 | 4.74 | 4.32 | 4.37 | 4.37 | 4.96 | Upgrade
|
| Quick Ratio | 2.52 | 2.13 | 1.04 | 1.21 | 0.99 | 0.66 | Upgrade
|
| Current Ratio | 5.03 | 4.42 | 2.92 | 3.39 | 3.16 | 1.95 | Upgrade
|
| Return on Equity (ROE) | -1.04% | 4.08% | 0.59% | -0.18% | 23.33% | 78.55% | Upgrade
|
| Return on Assets (ROA) | 1.47% | 4.94% | 0.61% | 0.30% | 6.77% | 14.94% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.09% | 4.27% | 0.53% | -0.20% | 13.61% | 31.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.90% | 9.80% | 1.20% | 0.60% | 13.70% | 35.70% | Upgrade
|
| Earnings Yield | -2.21% | 7.29% | 1.77% | -0.34% | 25.64% | 24.44% | Upgrade
|
| FCF Yield | 30.27% | 16.90% | 6.17% | 11.25% | 24.08% | 8.40% | Upgrade
|
| Buyback Yield / Dilution | 1.62% | -0.95% | -3.08% | 7.34% | -0.65% | -3.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.